Company
Ischemia Care
Ischemia Care is a rapidly growing diagnostics company engaged in development and commercialization of a breakthrough stroke blood testing platform that provides highly accurate diagnosis guidance to clinicians, enabling rapid treatment of complex and chronic patients.
Also known as ISCHEMIA CARE, LLC
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Oxford, OH, United States
- Customers
- clinicians
- Legal name
- ISCHEMIA CARE, LLC
Claim, correct or request removal
Record updated 28 September 2026
About
Ischemia Care (ISC) uses blood testing for stroke patients as a clinical workflow tool to improve patient outcomes and reduce hospital costs, by empowering clinicians with new information.
Funding snapshot
- Total raised
- $10.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $214K2022-09-14
Funding rounds
- Round, 2022
- $214K2022-09-14, SEC form D sold, 19 investors
- Round, 2021
- $1.4M2021-05-02, SEC form D sold, 34 investors
- Round, 2020
- $1.1M2020-04-24, SEC form D sold, 33 investors
- Round, 2019
- $1M2019-04-17, SEC form D sold, 25 investors
- Round, 2017
- $2.1M2017-12-11, SEC form D sold, 47 investors
- Round, 2016
- $1.7M2016-09-09, SEC form D sold, 45 investors
- Round, 2014
- $1.9M2014-09-25, SEC form D sold, 23 investors
- Round, 2013
- $396K2013-10-07, SEC form D sold, 20 investors
- Round, 2013
- $302K2013-01-31, SEC form D sold, 19 investors
- Round, 2011
- $750K2011-07-28, SEC form D sold, 22 investors
Products
- Other
- ISCDx
Loading relationship preview